At least 197 children were fathered by sperm donor with cancer-causing gene. Some have already died


A sperm donor with a rare genetic mutation linked to an elevated danger of growing cancer fathered at least 197 children throughout Europe, a few of whom have already died from the illness, in keeping with a brand new investigation.

The donor, who’s himself wholesome, had a uncommon mutation in a gene named TP53, which is more likely to trigger Li-Fraumeni syndrome, a uncommon dysfunction that will increase an individual’s danger of growing most cancers. He was unaware when he made the sperm donations that he was affected by the mutation.

In May, NCS reported that the person had fathered at least 67 children in eight European international locations, however a significant investigation revealed by information shops Wednesday has proven that the variety of affected children is the truth is far greater than beforehand thought.

According to the BBC, which is one among 14 European public service broadcasters concerned within the investigation, the brand new determine is the product of freedom of knowledge requests and interviews with docs and sufferers.

The man donated to a single personal sperm financial institution in Denmark named the European Sperm Bank (ESB), however his sperm was later used by 67 clinics in 14 completely different international locations. The remaining variety of affected children could also be greater nonetheless, “as data has not been obtained from all countries,” the BBC added.

It just isn’t identified what number of of those children have inherited the genetic mutation, however solely a small proportion of those that have achieved so will keep away from growing some type of most cancers of their lifetimes. People with the situation have a 90% likelihood of growing a number of sorts of most cancers by age 60, and round 50% accomplish that earlier than age 40, in keeping with the Cleveland Clinic.

Edwige Kasper, a biologist at Rouen University Hospital in France, recognized an preliminary 67 children throughout a presentation on the annual convention of the European Society of Human Genetics in May.

At the time, she mentioned 10 of the children had been identified with cancers akin to mind tumors and Hodgkin lymphoma, and one other 13 were carrying the gene however had not but developed a most cancers.

They would require common medical examinations as a consequence of their elevated danger of growing most cancers, and have a 50% likelihood of transmitting it on to their very own children, Kasper mentioned again in May.

On Wednesday, Clare Turnbull, professor of most cancers genetics on the Institute of Cancer Research, London, informed NCS that “Li Fraumeni syndrome is a devastating diagnosis to impart to a family.”

“There is a very high risk of cancer throughout the lifetime,” she added, “with a sizeable risk of childhood-onset cancers.”

The case “represents a highly unfortunate coincidence of two exceptionally unusual events: that the donor’s sperm carry mutations for an extremely rare genetic condition affecting fewer than 1 in 10,000 people and that his sperm has been used in the conception of such an extraordinarily large number of children,” she added.

Mary Herbert, professor of reproductive biology at Monash University in Melbourne, Australia, mentioned the investigation “highlights an urgent need for more comprehensive genetic screening of sperm donors and for strict cross-border controls on the number of children conceived from a single donor.”

“It is staggering that a single donor was used to conceive almost 200 children across a relatively small number of European countries,” she informed NCS in an announcement despatched by way of the Science Media Centre on Wednesday.

Julie Paulli Budtz, a spokeswoman for the European Sperm Bank (ESB), informed NCS that the corporate is “deeply affected by the case and the impact that the rare TP53 mutation has on a number of families, children and the donor.”

“They have our deepest sympathy,” she added.

“ESB tests and performs an individual medical assessment of all donors in full compliance with recognized and scientific practice and legislation,” Budtz mentioned, including that the ESB helps requires a restrict on the variety of children which are allowed to be born utilizing a single donor.

“The legislation on these areas is complex, with many and often conflicting considerations, and the implementation of the regulation differs greatly from country to country,” she added. “Hence, there is need for common and transparent European standards.”



Sources